ROCKVILLE, Md., Oct. 15, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today announced that Martin Rosendale, Chief Executive Officer of Cytomedix, will be presenting a corporate update at Security Research Associates’ Growth Stock Conference on Monday, October 19th at 4:00 p.m. (Eastern Time) at the Omni Hotel in New York, New York.
